多回波GRE-T2*序列诊断肝细胞癌的可行性研究
被引量:1
摘要
MRI平扫结合钆增强检查对肝细胞癌的诊断具有十分高的准确度[1,2]。然而由于含有钆的造影剂存在肾脏纤维化风险,对于伴有肾脏功能损害的病人,禁止使用钆增强检查[3,4],同样对于肝脏功能不全的病人也存在类似的风险[5]。
出处
《中国实验诊断学》
2012年第3期484-486,共3页
Chinese Journal of Laboratory Diagnosis
参考文献21
-
1Semelka RC,Martin DR,Balci C,et al.Focal liver lesions:com-parison of dual-phase CT and multisequence multiplanar MR ima-ging including dynamic gadolinium enhancement[J].J Magn Re-son Imaging,2001,13:397.
-
2Krinsky GA,Lee VS,et al.Transplantation for hepatocellularcarcinoma and cirrhosis:sensitivity of magnetic resonance ima-ging[J].Liver Transpl,2002,12:1156.
-
3Marckmann P,Skov L,et al.Nephrogenic systemic fibrosis:sus-pected causative role of gadodiamide used for contrast-enhancedmagnetic resonance imaging[J].J Am Soc Nephrol,2006,17:2359.
-
4Vitti RA.Gadolinium-based contrast agents and nephrogenic sys-temic fibrosis[J].Radiology,2009,250:959.
-
5Shenoy C.Gadolinium-induced nephrogenic systemic fibrosis inpatients with kidney and liver disease[J].Am J Med,2008,121:11.
-
6Thomsen HS.Imaging patients with chronic kidney disease:CINor NSF?[J].Radiol Med,2007,112(5):621.
-
7Piperno A,D'Alba R,Fargion S,et al.Liver iron concentration inchronic viral hepatitis:a study of 98patients[J].Eur J Gastroen-terol Hepatol,1995,7(12):1203.
-
8Ludwig J,Hashimoto E,Porayko MK,et al.Hemosiderosis in cir-rhosis:a study of 447native livers[J].Gastroenterology,1997,112(3):882.
-
9Chapoutot C,Esslimani M,et al.Liver iron excess in patientswith hepatocellular carcinoma developed on viral C cirrhosis[J].Gut,2000,46:711.
-
10Tan MG,Kumarasinghe MP,et al.Modulation of iron-regulato-ry genes in human hepatocellular carcinoma and its physiologicalconsequences[J].Exp Biol Med,2009,234(6):693.
二级参考文献10
-
1邬颖华,宋彬,徐隽,印隆林,毛芸.VIBE序列在原发性肝癌MRI诊断中的价值[J].中国普外基础与临床杂志,2005,12(2):184-187. 被引量:11
-
2Ichikawa T,Kitamura T,Nakajima H,et al.Hypervascular hepatocellular carcinoma:can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?[J].AJR Am J Roentgenol,2002; 179(3):751
-
3Kirchin MA,Pirovano GP,Spinazzi A.Gadobenate dimeglumine (Gd-BOPTA).An overview[J].Invest Radiol,1998; 33(11):798
-
4Caudana R,Morana G,Pirovano GP,et al.Focal malignant hepatic lesions:MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase Ⅱ clinical application[J].Radiology,1996; 199(2):513
-
5Vogl TJ,Stupavsky A,Pegios W,et al.Hepatocellular carcinoma:evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation[J].Radiology,1997; 205(3):721
-
6Pirovano G,Vanzulli A,Marti-Bonmati L,et al.Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions[J].AJR Am J Roentgenol,2000; 175(4):1111
-
7Kuwatsuru R,Kadoya M,Ohtomo K,et al.Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors[J].Invest Radiol,2001; 36(11):632
-
8Hayashi M,Matsui O,Ueda K,et al.Progression to hypervascular hepatocellular carcinoma:correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material[J].Radiology,2002; 225(1):143
-
9Grazioli L,Morana G,Caudana R,et al.Hepatocellular carcinoma:correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings[J].Invest Radiol,2000; 35(1):25
-
10陈卫霞,闵鹏秋,周翔平,宋彬,刘燕,沈明恩,李真林,杨敏.肝细胞癌螺旋CT增强双期扫描边缘强化与病理对照研究[J].中华放射学杂志,2002,36(2):152-156. 被引量:42
共引文献3
-
1李迎春,宋彬,蒋莉莉,唐鹤涵,何艳梅,蒋晓忠,印隆林,吴俊华.新型MR造影剂钆贝葡胺诊断肝脏局灶性结节样增生的价值(附5例报告)[J].中国普外基础与临床杂志,2007,14(5):598-604. 被引量:7
-
2尹光平,童玉云,孙文健.1718磁共振钆贝葡胺(莫迪司)造影剂在肝脏疾病的应用[J].医疗装备,2016,29(3):43-44.
-
3李镓宏,周莹,张顺源,陈娇.莫迪司在肝脏占位病变诊断中的应用价值[J].影像研究与医学应用,2018,2(13):236-238. 被引量:3
同被引文献9
-
1王梅,张龙江,卢光明.肝硬化相关结节的MRI研究与进展[J].国际医学放射学杂志,2012,35(5):437-442. 被引量:19
-
2陈晓丽,李杭,陈天武.肝纤维化的磁共振定量诊断与分期研究进展[J].国际医学放射学杂志,2013,36(6):545-549. 被引量:5
-
3陈伟,周胜利.DWI在食管癌定量及定期诊断中的价值[J].临床放射学杂志,2014,33(3):388-393. 被引量:15
-
4单崴,陈思争.ADC在肝纤维化患者诊断中的应用价值研究(附56例报告)[J].医学影像学杂志,2014,24(7):1172-1174. 被引量:11
-
5李秋菊,赵周社,于兵,石喻,李加慧,郭启勇.磁共振扩散加权成像在肝纤维化中的应用进展[J].中国临床医学影像杂志,2014,25(7):502-506. 被引量:16
-
6张小彪,马菁,郭玉林,李婷,何花,蔡磊,侯登华.3.0 T磁共振对肝硬化背景上小肝癌检出的价值[J].临床放射学杂志,2014,33(8):1193-1197. 被引量:16
-
7高希春,陆文杰,刘昊元,魏铭,郑生喜.磁共振3种T_2加权成像序列在胃癌中的成像质量对比[J].中国临床研究,2014,27(9):1038-1041. 被引量:2
-
8莫旭林,刘彪,黄波,魏景欣.磁共振弥散加权成像ADC值和骨髓对比率对脊椎转移瘤的诊断价值[J].临床医学,2014,34(10):104-105. 被引量:4
-
9刘玲峰,陆海英,于岩岩,吴赤红,田秀兰.FibroScan检测与超声检查对肝纤维化程度诊断价值的对比分析[J].临床肝胆病杂志,2014,30(10):1045-1049. 被引量:17
二级引证文献3
-
1刘渊,董景辉,安维民,任洪伟,叶慧义.慢性乙型病毒性肝炎患者不同场强下磁共振扩散加权成像定量对比分析[J].中华医学杂志,2017,97(21):1638-1642. 被引量:3
-
2王小凤,舒健,唐光才,杨述根,陆笑非.磁共振T2值评估大鼠肝纤维化的应用价值[J].中国医学影像学杂志,2017,25(6):401-404. 被引量:4
-
3刘渊,叶慧义.磁共振扩散加权成像在慢性乙型病毒性肝炎中的应用进展[J].中国医学影像学杂志,2017,25(8):635-636. 被引量:4
-
1林志东,毛盛名,卜巨源,邹劲林.大肠癌术中植入氟尿嘧啶缓释剂安全性及其临床疗效的研究[J].中华普通外科学文献(电子版),2013,7(5):32-35. 被引量:7
-
2张少平,陈向荣,许淑惠,陈杰云,汪林.MRT1 WI脂肪抑制序列诊断脊柱转移瘤的价值[J].中国医学影像学杂志,2003,11(6):466-467. 被引量:3
-
3刘珊,王惠明,丁国华.上皮间质转化在肾脏纤维化中的分子机制研究进展[J].临床内科杂志,2016,33(6):428-430. 被引量:3
-
4易永祥,胡亮,韩建波,赵亮,张郁峰,刘俊卯,张继宗,殷国平.切除肝癌联合定量微波消融治疗脾功能亢进患者术后并发症的相关因素分析[J].中华老年医学杂志,2014,33(9):969-972. 被引量:5
-
5郭志玲,付建斌,贾国强.显微镜下型多血管炎肾损害23例临床病理分析[J].中华风湿病学杂志,2005,9(10):608-610. 被引量:2
-
6钟永忠,谌达程,曾彩虹.肾脏纤维化中的新角色——血管周细胞[J].肾脏病与透析肾移植杂志,2015,24(4):360-364. 被引量:2
-
7闫丽红,赵鑫,肖宜昌,张小安.探讨DWI在子宫内膜癌早期病变的诊断价值[J].医药论坛杂志,2016,37(3):25-26. 被引量:3
-
8张水兰,孙小萍,时红梅.反应停治疗难治性多发性骨髓瘤25例[J].第四军医大学学报,2005,26(6):550-550. 被引量:3
-
9熊伟立,肖昆,林永开.MR不同序列对子宫内膜癌盆腔淋巴结的检出和淋巴结转移的诊断价值[J].医学影像学杂志,2015,25(11):2070-2072. 被引量:5
-
10付坤玥,纪志英,秦昕东,苑晶.脊柱转移瘤的MR不同序列诊断价值比较[J].医学影像学杂志,2014,24(9):1604-1607. 被引量:2